| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| muscle organ development | 4 out of 20 genes, 20.0% | 6 out of 533 genes, 1.1% | 2.081162e-05 |
| regulation of biological quality | 9 out of 20 genes, 45.0% | 71 out of 533 genes, 13.3% | 0.0004044025 |
| regulation of cytokine production | 4 out of 20 genes, 20.0% | 11 out of 533 genes, 2.1% | 0.0004049751 |
| muscle structure development | 4 out of 20 genes, 20.0% | 11 out of 533 genes, 2.1% | 0.0004049751 |
| positive regulation of leukocyte activation | 3 out of 20 genes, 15.0% | 5 out of 533 genes, 0.9% | 0.0004326867 |
| striated muscle tissue development | 3 out of 20 genes, 15.0% | 5 out of 533 genes, 0.9% | 0.0004326867 |
| positive regulation of cell activation | 3 out of 20 genes, 15.0% | 5 out of 533 genes, 0.9% | 0.0004326867 |
| muscle cell development | 3 out of 20 genes, 15.0% | 5 out of 533 genes, 0.9% | 0.0004326867 |
| striated muscle cell development | 3 out of 20 genes, 15.0% | 5 out of 533 genes, 0.9% | 0.0004326867 |
| muscle tissue development | 3 out of 20 genes, 15.0% | 5 out of 533 genes, 0.9% | 0.0004326867 |
| regulation of anatomical structure size | 4 out of 20 genes, 20.0% | 13 out of 533 genes, 2.4% | 0.0008353404 |
| regulation of multicellular organismal process | 7 out of 20 genes, 35.0% | 49 out of 533 genes, 9.2% | 0.001111724 |
| response to osmotic stress | 2 out of 20 genes, 10.0% | 2 out of 533 genes, 0.4% | 0.001340123 |
| regulation of blood pressure | 2 out of 20 genes, 10.0% | 2 out of 533 genes, 0.4% | 0.001340123 |
| ruffle organization | 2 out of 20 genes, 10.0% | 2 out of 533 genes, 0.4% | 0.001340123 |
| striated muscle cell differentiation | 3 out of 20 genes, 15.0% | 7 out of 533 genes, 1.3% | 0.001442445 |
| cellular component morphogenesis | 5 out of 20 genes, 25.0% | 25 out of 533 genes, 4.7% | 0.001444093 |
| cell projection organization | 5 out of 20 genes, 25.0% | 27 out of 533 genes, 5.1% | 0.002089774 |
| regulation of response to stress | 5 out of 20 genes, 25.0% | 27 out of 533 genes, 5.1% | 0.002089774 |
| regulation of leukocyte activation | 3 out of 20 genes, 15.0% | 8 out of 533 genes, 1.5% | 0.002252429 |
| regulation of cell activation | 3 out of 20 genes, 15.0% | 8 out of 533 genes, 1.5% | 0.002252429 |
| locomotion | 5 out of 20 genes, 25.0% | 28 out of 533 genes, 5.3% | 0.002482681 |
| chemotaxis | 4 out of 20 genes, 20.0% | 17 out of 533 genes, 3.2% | 0.002519775 |
| tissue development | 4 out of 20 genes, 20.0% | 17 out of 533 genes, 3.2% | 0.002519775 |
| taxis | 4 out of 20 genes, 20.0% | 17 out of 533 genes, 3.2% | 0.002519775 |
| cell development | 5 out of 20 genes, 25.0% | 29 out of 533 genes, 5.4% | 0.002927458 |
| regulation of actin filament polymerization | 3 out of 20 genes, 15.0% | 9 out of 533 genes, 1.7% | 0.003297437 |
| muscle cell differentiation | 3 out of 20 genes, 15.0% | 9 out of 533 genes, 1.7% | 0.003297437 |
| muscle organ morphogenesis | 2 out of 20 genes, 10.0% | 3 out of 533 genes, 0.6% | 0.003929514 |
| cardiac muscle tissue development | 2 out of 20 genes, 10.0% | 3 out of 533 genes, 0.6% | 0.003929514 |
| skeletal muscle fiber development | 2 out of 20 genes, 10.0% | 3 out of 533 genes, 0.6% | 0.003929514 |
| muscle fiber development | 2 out of 20 genes, 10.0% | 3 out of 533 genes, 0.6% | 0.003929514 |
| cardiac muscle tissue morphogenesis | 2 out of 20 genes, 10.0% | 3 out of 533 genes, 0.6% | 0.003929514 |
| muscle tissue morphogenesis | 2 out of 20 genes, 10.0% | 3 out of 533 genes, 0.6% | 0.003929514 |
| organ development | 5 out of 20 genes, 25.0% | 31 out of 533 genes, 5.8% | 0.003988417 |
| regulation of actin polymerization or depolymerization | 3 out of 20 genes, 15.0% | 10 out of 533 genes, 1.9% | 0.004597429 |
| regulation of actin filament length | 3 out of 20 genes, 15.0% | 10 out of 533 genes, 1.9% | 0.004597429 |
| regulation of protein polymerization | 3 out of 20 genes, 15.0% | 10 out of 533 genes, 1.9% | 0.004597429 |
| positive regulation of immune system process | 3 out of 20 genes, 15.0% | 11 out of 533 genes, 2.1% | 0.006169599 |
| regulation of actin cytoskeleton organization | 3 out of 20 genes, 15.0% | 11 out of 533 genes, 2.1% | 0.006169599 |
| regulation of actin filament-based process | 3 out of 20 genes, 15.0% | 11 out of 533 genes, 2.1% | 0.006169599 |
| positive regulation of multicellular organismal process | 3 out of 20 genes, 15.0% | 11 out of 533 genes, 2.1% | 0.006169599 |
| cellular component movement | 5 out of 20 genes, 25.0% | 35 out of 533 genes, 6.6% | 0.006907978 |
| cellular component organization | 12 out of 20 genes, 60.0% | 169 out of 533 genes, 31.7% | 0.007348602 |
| regulation of response to biotic stimulus | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| heart morphogenesis | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| circulatory system process | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| heart process | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| skeletal muscle tissue development | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| blood circulation | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| myofibril assembly | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| actomyosin structure organization | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| actin-myosin filament sliding | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| cellular response to oxidative stress | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| cellular response to reactive oxygen species | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| innate immune response | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| positive regulation of lymphocyte activation | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| heart contraction | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| skeletal muscle organ development | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| actin-mediated cell contraction | 2 out of 20 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.007681688 |
| system development | 6 out of 20 genes, 30.0% | 51 out of 533 genes, 9.6% | 0.007788299 |
| regulation of cellular component size | 3 out of 20 genes, 15.0% | 12 out of 533 genes, 2.3% | 0.008028561 |
| single-organism process | 18 out of 20 genes, 90.0% | 341 out of 533 genes, 64.0% | 0.008574266 |
| regulation of localization | 6 out of 20 genes, 30.0% | 52 out of 533 genes, 9.8% | 0.008593476 |
| regulation of developmental process | 5 out of 20 genes, 25.0% | 37 out of 533 genes, 6.9% | 0.008830492 |
| response to external stimulus | 4 out of 20 genes, 20.0% | 24 out of 533 genes, 4.5% | 0.00946528 |
| organ morphogenesis | 3 out of 20 genes, 15.0% | 13 out of 533 genes, 2.4% | 0.01018653 |
| regulation of response to stimulus | 7 out of 20 genes, 35.0% | 71 out of 533 genes, 13.3% | 0.01027864 |
| anatomical structure morphogenesis | 5 out of 20 genes, 25.0% | 39 out of 533 genes, 7.3% | 0.01110324 |
| response to chemical stimulus | 7 out of 20 genes, 35.0% | 72 out of 533 genes, 13.5% | 0.01111809 |
| positive regulation of cytokine production | 2 out of 20 genes, 10.0% | 5 out of 533 genes, 0.9% | 0.01251436 |
| muscle system process | 2 out of 20 genes, 10.0% | 5 out of 533 genes, 0.9% | 0.01251436 |
| muscle contraction | 2 out of 20 genes, 10.0% | 5 out of 533 genes, 0.9% | 0.01251436 |
| regulation of muscle contraction | 2 out of 20 genes, 10.0% | 5 out of 533 genes, 0.9% | 0.01251436 |
| positive regulation of cytoskeleton organization | 2 out of 20 genes, 10.0% | 5 out of 533 genes, 0.9% | 0.01251436 |
| axon guidance | 3 out of 20 genes, 15.0% | 14 out of 533 genes, 2.6% | 0.01265347 |
| cardiovascular system development | 3 out of 20 genes, 15.0% | 14 out of 533 genes, 2.6% | 0.01265347 |
| circulatory system development | 3 out of 20 genes, 15.0% | 14 out of 533 genes, 2.6% | 0.01265347 |
| regulation of immune system process | 4 out of 20 genes, 20.0% | 26 out of 533 genes, 4.9% | 0.01267463 |
| cellular component organization or biogenesis | 12 out of 20 genes, 60.0% | 180 out of 533 genes, 33.8% | 0.01295589 |
| response to stress | 7 out of 20 genes, 35.0% | 76 out of 533 genes, 14.3% | 0.01499883 |
| regulation of cell migration | 3 out of 20 genes, 15.0% | 15 out of 533 genes, 2.8% | 0.01543731 |
| regulation of locomotion | 3 out of 20 genes, 15.0% | 15 out of 533 genes, 2.8% | 0.01543731 |
| regulation of protein complex assembly | 3 out of 20 genes, 15.0% | 15 out of 533 genes, 2.8% | 0.01543731 |
| negative regulation of cellular component organization | 3 out of 20 genes, 15.0% | 15 out of 533 genes, 2.8% | 0.01543731 |
| regulation of cell motility | 3 out of 20 genes, 15.0% | 15 out of 533 genes, 2.8% | 0.01543731 |
| response to reactive oxygen species | 2 out of 20 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.01834925 |
| actin filament-based movement | 2 out of 20 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.01834925 |
| negative regulation of actin filament depolymerization | 2 out of 20 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.01834925 |
| negative regulation of actin filament polymerization | 2 out of 20 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.01834925 |
| actin filament capping | 2 out of 20 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.01834925 |
| regulation of muscle system process | 2 out of 20 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.01834925 |
| defense response | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| axonogenesis | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| neuron projection development | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| cell morphogenesis involved in neuron differentiation | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| neuron projection morphogenesis | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| cell motility | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| regulation of cellular component movement | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| regulation of cytoskeleton organization | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| localization of cell | 3 out of 20 genes, 15.0% | 16 out of 533 genes, 3.0% | 0.018544 |
| negative regulation of cellular process | 8 out of 20 genes, 40.0% | 99 out of 533 genes, 18.6% | 0.01910171 |
| negative regulation of apoptotic process | 3 out of 20 genes, 15.0% | 17 out of 533 genes, 3.2% | 0.02197777 |
| regulation of cellular component biogenesis | 3 out of 20 genes, 15.0% | 17 out of 533 genes, 3.2% | 0.02197777 |
| regulation of immune effector process | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| inflammatory response | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| cellular component assembly involved in morphogenesis | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| regulation of lipid metabolic process | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| regulation of actin filament depolymerization | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| epithelial cell differentiation | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| negative regulation of protein polymerization | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| negative regulation of protein complex disassembly | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| regulation of lymphocyte activation | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| negative regulation of protein depolymerization | 2 out of 20 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.02511197 |
| single-organism developmental process | 6 out of 20 genes, 30.0% | 65 out of 533 genes, 12.2% | 0.02539107 |
| cell morphogenesis involved in differentiation | 3 out of 20 genes, 15.0% | 18 out of 533 genes, 3.4% | 0.02574116 |
| negative regulation of programmed cell death | 3 out of 20 genes, 15.0% | 18 out of 533 genes, 3.4% | 0.02574116 |
| negative regulation of cell death | 3 out of 20 genes, 15.0% | 18 out of 533 genes, 3.4% | 0.02574116 |
| cellular response to chemical stimulus | 5 out of 20 genes, 25.0% | 48 out of 533 genes, 9.0% | 0.02643373 |
| regulation of cellular process | 14 out of 20 genes, 70.0% | 249 out of 533 genes, 46.7% | 0.02833236 |
| neuron development | 3 out of 20 genes, 15.0% | 19 out of 533 genes, 3.6% | 0.02983521 |
| cellular response to oxygen-containing compound | 3 out of 20 genes, 15.0% | 19 out of 533 genes, 3.6% | 0.02983521 |
| negative regulation of biological process | 8 out of 20 genes, 40.0% | 107 out of 533 genes, 20.1% | 0.0301206 |
| biological regulation | 15 out of 20 genes, 75.0% | 279 out of 533 genes, 52.3% | 0.03102854 |
| response to stimulus | 11 out of 20 genes, 55.0% | 175 out of 533 genes, 32.8% | 0.03109232 |
| blood vessel development | 2 out of 20 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.03273182 |
| vasculature development | 2 out of 20 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.03273182 |
| response to oxidative stress | 2 out of 20 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.03273182 |
| negative regulation of protein complex assembly | 2 out of 20 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.03273182 |
| negative regulation of cytoskeleton organization | 2 out of 20 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.03273182 |
| regulation of protein depolymerization | 2 out of 20 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.03273182 |
| cell part morphogenesis | 3 out of 20 genes, 15.0% | 20 out of 533 genes, 3.8% | 0.03425958 |
| anatomical structure formation involved in morphogenesis | 3 out of 20 genes, 15.0% | 20 out of 533 genes, 3.8% | 0.03425958 |
| cell projection morphogenesis | 3 out of 20 genes, 15.0% | 20 out of 533 genes, 3.8% | 0.03425958 |
| cellular response to stimulus | 9 out of 20 genes, 45.0% | 133 out of 533 genes, 25.0% | 0.03750591 |
| multicellular organismal development | 6 out of 20 genes, 30.0% | 71 out of 533 genes, 13.3% | 0.03798053 |
| regulation of transport | 4 out of 20 genes, 20.0% | 36 out of 533 genes, 6.8% | 0.03898652 |
| response to abiotic stimulus | 3 out of 20 genes, 15.0% | 21 out of 533 genes, 3.9% | 0.03901264 |
| nucleosome assembly | 2 out of 20 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.04114165 |
| endocytosis | 2 out of 20 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.04114165 |
| heart development | 2 out of 20 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.04114165 |
| negative regulation of organelle organization | 2 out of 20 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.04114165 |
| cell projection assembly | 2 out of 20 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.04114165 |
| chromatin assembly | 2 out of 20 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.04114165 |
| regulation of protein complex disassembly | 2 out of 20 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.04114165 |
| tissue morphogenesis | 2 out of 20 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.04114165 |
| positive regulation of response to stimulus | 4 out of 20 genes, 20.0% | 37 out of 533 genes, 6.9% | 0.04264179 |
| cell morphogenesis | 3 out of 20 genes, 15.0% | 22 out of 533 genes, 4.1% | 0.04409159 |
| neuron differentiation | 3 out of 20 genes, 15.0% | 22 out of 533 genes, 4.1% | 0.04409159 |
| regulation of organelle organization | 3 out of 20 genes, 15.0% | 22 out of 533 genes, 4.1% | 0.04409159 |
| anatomical structure development | 6 out of 20 genes, 30.0% | 74 out of 533 genes, 13.9% | 0.0456157 |
| immune system process | 4 out of 20 genes, 20.0% | 38 out of 533 genes, 7.1% | 0.04649128 |
| single-organism cellular process | 16 out of 20 genes, 80.0% | 320 out of 533 genes, 60.0% | 0.04813586 |
| cell differentiation | 5 out of 20 genes, 25.0% | 56 out of 533 genes, 10.5% | 0.04833314 |
| response to wounding | 3 out of 20 genes, 15.0% | 23 out of 533 genes, 4.3% | 0.04949258 |
| DNA packaging | 2 out of 20 genes, 10.0% | 10 out of 533 genes, 1.9% | 0.0502777 |
| chromatin assembly or disassembly | 2 out of 20 genes, 10.0% | 10 out of 533 genes, 1.9% | 0.0502777 |
| immune response | 2 out of 20 genes, 10.0% | 10 out of 533 genes, 1.9% | 0.0502777 |
| positive regulation of organelle organization | 2 out of 20 genes, 10.0% | 10 out of 533 genes, 1.9% | 0.0502777 |
| nucleosome organization | 2 out of 20 genes, 10.0% | 10 out of 533 genes, 1.9% | 0.0502777 |
| protein-DNA complex assembly | 2 out of 20 genes, 10.0% | 10 out of 533 genes, 1.9% | 0.0502777 |
| regulation of signal transduction | 5 out of 20 genes, 25.0% | 58 out of 533 genes, 10.9% | 0.05515825 |
| regulation of biological process | 14 out of 20 genes, 70.0% | 267 out of 533 genes, 50.1% | 0.05519477 |
| cell activation | 2 out of 20 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.0600795 |
| cell proliferation | 2 out of 20 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.0600795 |
| extracellular matrix organization | 2 out of 20 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.0600795 |
| extracellular structure organization | 2 out of 20 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.0600795 |
| epithelium development | 2 out of 20 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.0600795 |
| DNA conformation change | 2 out of 20 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.0600795 |
| protein-DNA complex subunit organization | 2 out of 20 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.0600795 |
| cellular developmental process | 5 out of 20 genes, 25.0% | 61 out of 533 genes, 11.4% | 0.06644573 |
| regulation of defense response | 2 out of 20 genes, 10.0% | 12 out of 533 genes, 2.3% | 0.07048969 |
| neurogenesis | 3 out of 20 genes, 15.0% | 27 out of 533 genes, 5.1% | 0.07420756 |
| generation of neurons | 3 out of 20 genes, 15.0% | 27 out of 533 genes, 5.1% | 0.07420756 |
| response to oxygen-containing compound | 3 out of 20 genes, 15.0% | 27 out of 533 genes, 5.1% | 0.07420756 |
| positive regulation of cellular process | 7 out of 20 genes, 35.0% | 106 out of 533 genes, 19.9% | 0.08057639 |
| regulation of I-kappaB kinase/NF-kappaB cascade | 2 out of 20 genes, 10.0% | 13 out of 533 genes, 2.4% | 0.08145391 |
| regulation of cellular component organization | 4 out of 20 genes, 20.0% | 46 out of 533 genes, 8.6% | 0.08427678 |
| regulation of cell communication | 5 out of 20 genes, 25.0% | 66 out of 533 genes, 12.4% | 0.08807821 |
| regulation of signaling | 5 out of 20 genes, 25.0% | 67 out of 533 genes, 12.6% | 0.09282594 |
| cellular lipid metabolic process | 2 out of 20 genes, 10.0% | 14 out of 533 genes, 2.6% | 0.09292064 |
| positive regulation of transport | 2 out of 20 genes, 10.0% | 14 out of 533 genes, 2.6% | 0.09292064 |
| negative regulation of developmental process | 2 out of 20 genes, 10.0% | 14 out of 533 genes, 2.6% | 0.09292064 |
| regulation of protein transport | 2 out of 20 genes, 10.0% | 14 out of 533 genes, 2.6% | 0.09292064 |
| single-multicellular organism process | 6 out of 20 genes, 30.0% | 88 out of 533 genes, 16.5% | 0.09416637 |
| homeostatic process | 3 out of 20 genes, 15.0% | 30 out of 533 genes, 5.6% | 0.09581046 |
| cell migration | 2 out of 20 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.1048412 |
| actin cytoskeleton organization | 2 out of 20 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.1048412 |
| wound healing | 2 out of 20 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.1048412 |
| regulation of system process | 2 out of 20 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.1048412 |
| positive regulation of hydrolase activity | 2 out of 20 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.1048412 |
| regulation of establishment of protein localization | 2 out of 20 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.1048412 |
| regulation of cellular response to stress | 2 out of 20 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.1048412 |
| regulation of intracellular protein kinase cascade | 3 out of 20 genes, 15.0% | 32 out of 533 genes, 6.0% | 0.1115438 |
| multicellular organismal process | 6 out of 20 genes, 30.0% | 93 out of 533 genes, 17.4% | 0.1168314 |
| embryo development | 2 out of 20 genes, 10.0% | 16 out of 533 genes, 3.0% | 0.1171693 |
| regulation of anatomical structure morphogenesis | 2 out of 20 genes, 10.0% | 16 out of 533 genes, 3.0% | 0.1171693 |
| response to growth factor stimulus | 2 out of 20 genes, 10.0% | 16 out of 533 genes, 3.0% | 0.1171693 |
| cellular response to growth factor stimulus | 2 out of 20 genes, 10.0% | 16 out of 533 genes, 3.0% | 0.1171693 |
| positive regulation of biological process | 7 out of 20 genes, 35.0% | 116 out of 533 genes, 21.8% | 0.1202147 |
| developmental process | 6 out of 20 genes, 30.0% | 94 out of 533 genes, 17.6% | 0.1216979 |
| single-organism transport | 6 out of 20 genes, 30.0% | 94 out of 533 genes, 17.6% | 0.1216979 |
| response to organic substance | 4 out of 20 genes, 20.0% | 53 out of 533 genes, 9.9% | 0.1271112 |
| positive regulation of catalytic activity | 3 out of 20 genes, 15.0% | 34 out of 533 genes, 6.4% | 0.1282512 |
| apoptotic process | 2 out of 20 genes, 10.0% | 17 out of 533 genes, 3.2% | 0.1298615 |
| programmed cell death | 2 out of 20 genes, 10.0% | 17 out of 533 genes, 3.2% | 0.1298615 |
| cellular component assembly | 5 out of 20 genes, 25.0% | 74 out of 533 genes, 13.9% | 0.1298831 |
| regulation of cell death | 3 out of 20 genes, 15.0% | 35 out of 533 genes, 6.6% | 0.1369443 |
| regulation of apoptotic process | 3 out of 20 genes, 15.0% | 35 out of 533 genes, 6.6% | 0.1369443 |
| regulation of programmed cell death | 3 out of 20 genes, 15.0% | 35 out of 533 genes, 6.6% | 0.1369443 |
| cell death | 2 out of 20 genes, 10.0% | 18 out of 533 genes, 3.4% | 0.1428766 |
| death | 2 out of 20 genes, 10.0% | 18 out of 533 genes, 3.4% | 0.1428766 |
| positive regulation of cellular component organization | 2 out of 20 genes, 10.0% | 18 out of 533 genes, 3.4% | 0.1428766 |
| nervous system development | 3 out of 20 genes, 15.0% | 36 out of 533 genes, 6.8% | 0.1458496 |
| actin filament-based process | 2 out of 20 genes, 10.0% | 19 out of 533 genes, 3.6% | 0.1561756 |
| localization | 8 out of 20 genes, 40.0% | 148 out of 533 genes, 27.8% | 0.1603632 |
| system process | 2 out of 20 genes, 10.0% | 20 out of 533 genes, 3.8% | 0.1697218 |
| cellular membrane organization | 2 out of 20 genes, 10.0% | 20 out of 533 genes, 3.8% | 0.1697218 |
| regulation of protein localization | 2 out of 20 genes, 10.0% | 20 out of 533 genes, 3.8% | 0.1697218 |
| membrane organization | 2 out of 20 genes, 10.0% | 20 out of 533 genes, 3.8% | 0.1697218 |
| cellular response to organic substance | 3 out of 20 genes, 15.0% | 39 out of 533 genes, 7.3% | 0.1737296 |
| macromolecular complex subunit organization | 5 out of 20 genes, 25.0% | 82 out of 533 genes, 15.4% | 0.1798747 |
| cellular response to stress | 3 out of 20 genes, 15.0% | 40 out of 533 genes, 7.5% | 0.1833746 |
| lipid metabolic process | 2 out of 20 genes, 10.0% | 21 out of 533 genes, 3.9% | 0.1834806 |
| chromatin organization | 2 out of 20 genes, 10.0% | 22 out of 533 genes, 4.1% | 0.1974195 |
| regulation of MAPK cascade | 2 out of 20 genes, 10.0% | 22 out of 533 genes, 4.1% | 0.1974195 |
| transport | 7 out of 20 genes, 35.0% | 132 out of 533 genes, 24.8% | 0.2030299 |
| regulation of phosphate metabolic process | 3 out of 20 genes, 15.0% | 42 out of 533 genes, 7.9% | 0.2031262 |
| regulation of phosphorus metabolic process | 3 out of 20 genes, 15.0% | 42 out of 533 genes, 7.9% | 0.2031262 |
| establishment of localization | 7 out of 20 genes, 35.0% | 133 out of 533 genes, 25.0% | 0.2089359 |
| regulation of cellular localization | 2 out of 20 genes, 10.0% | 23 out of 533 genes, 4.3% | 0.2115078 |
| regulation of multicellular organismal development | 2 out of 20 genes, 10.0% | 23 out of 533 genes, 4.3% | 0.2115078 |
| positive regulation of molecular function | 3 out of 20 genes, 15.0% | 43 out of 533 genes, 8.1% | 0.2132111 |
| regulation of cell differentiation | 2 out of 20 genes, 10.0% | 24 out of 533 genes, 4.5% | 0.2257166 |
| cellular component biogenesis | 5 out of 20 genes, 25.0% | 89 out of 533 genes, 16.7% | 0.229348 |
| protein targeting to membrane | 2 out of 20 genes, 10.0% | 26 out of 533 genes, 4.9% | 0.2543892 |
| regulation of hydrolase activity | 2 out of 20 genes, 10.0% | 26 out of 533 genes, 4.9% | 0.2543892 |
| regulation of metabolic process | 8 out of 20 genes, 40.0% | 166 out of 533 genes, 31.1% | 0.2604287 |
| chromosome organization | 2 out of 20 genes, 10.0% | 27 out of 533 genes, 5.1% | 0.2688038 |
| cytoskeleton organization | 2 out of 20 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.2832402 |
| regulation of phosphorylation | 2 out of 20 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.2832402 |
| macromolecular complex assembly | 3 out of 20 genes, 15.0% | 50 out of 533 genes, 9.4% | 0.2867185 |
| regulation of catalytic activity | 3 out of 20 genes, 15.0% | 52 out of 533 genes, 9.8% | 0.3083528 |
| cell adhesion | 2 out of 20 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.3120968 |
| biological adhesion | 2 out of 20 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.3120968 |
| cellular macromolecular complex assembly | 2 out of 20 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.3120968 |
| regulation of primary metabolic process | 7 out of 20 genes, 35.0% | 150 out of 533 genes, 28.1% | 0.3197942 |
| multi-organism process | 3 out of 20 genes, 15.0% | 54 out of 533 genes, 10.1% | 0.330128 |
| positive regulation of signal transduction | 2 out of 20 genes, 10.0% | 32 out of 533 genes, 6.0% | 0.3408084 |
| positive regulation of cell communication | 2 out of 20 genes, 10.0% | 32 out of 533 genes, 6.0% | 0.3408084 |
| positive regulation of signaling | 2 out of 20 genes, 10.0% | 32 out of 533 genes, 6.0% | 0.3408084 |
| organelle organization | 4 out of 20 genes, 20.0% | 80 out of 533 genes, 15.0% | 0.3520153 |
| negative regulation of gene expression | 2 out of 20 genes, 10.0% | 33 out of 533 genes, 6.2% | 0.3550682 |
| DNA metabolic process | 2 out of 20 genes, 10.0% | 34 out of 533 genes, 6.4% | 0.3692443 |
| vesicle-mediated transport | 2 out of 20 genes, 10.0% | 35 out of 533 genes, 6.6% | 0.3833231 |
| positive regulation of protein metabolic process | 2 out of 20 genes, 10.0% | 36 out of 533 genes, 6.8% | 0.3972921 |
| regulation of protein metabolic process | 3 out of 20 genes, 15.0% | 61 out of 533 genes, 11.4% | 0.4064676 |
| protein complex subunit organization | 3 out of 20 genes, 15.0% | 61 out of 533 genes, 11.4% | 0.4064676 |
| protein targeting | 2 out of 20 genes, 10.0% | 39 out of 533 genes, 7.3% | 0.4384302 |
| regulation of cell proliferation | 2 out of 20 genes, 10.0% | 39 out of 533 genes, 7.3% | 0.4384302 |
| regulation of molecular function | 3 out of 20 genes, 15.0% | 66 out of 533 genes, 12.4% | 0.4600686 |
| viral reproduction | 2 out of 20 genes, 10.0% | 42 out of 533 genes, 7.9% | 0.4782193 |
| multi-organism cellular process | 2 out of 20 genes, 10.0% | 42 out of 533 genes, 7.9% | 0.4782193 |
| regulation of cellular metabolic process | 6 out of 20 genes, 30.0% | 148 out of 533 genes, 27.8% | 0.4964983 |
| protein transport | 3 out of 20 genes, 15.0% | 72 out of 533 genes, 13.5% | 0.522149 |
| signal transduction | 4 out of 20 genes, 20.0% | 99 out of 533 genes, 18.6% | 0.5266306 |
| establishment of protein localization | 3 out of 20 genes, 15.0% | 73 out of 533 genes, 13.7% | 0.5321889 |
| positive regulation of metabolic process | 3 out of 20 genes, 15.0% | 75 out of 533 genes, 14.1% | 0.5519691 |
| signaling | 4 out of 20 genes, 20.0% | 103 out of 533 genes, 19.3% | 0.5614952 |
| single organism signaling | 4 out of 20 genes, 20.0% | 103 out of 533 genes, 19.3% | 0.5614952 |
| cellular catabolic process | 4 out of 20 genes, 20.0% | 104 out of 533 genes, 19.5% | 0.570039 |
| reproductive process | 2 out of 20 genes, 10.0% | 50 out of 533 genes, 9.4% | 0.5763845 |
| intracellular protein transport | 2 out of 20 genes, 10.0% | 51 out of 533 genes, 9.6% | 0.587767 |
| regulation of cellular protein metabolic process | 2 out of 20 genes, 10.0% | 51 out of 533 genes, 9.6% | 0.587767 |
| cell communication | 4 out of 20 genes, 20.0% | 107 out of 533 genes, 20.1% | 0.5952146 |
| negative regulation of macromolecule metabolic process | 2 out of 20 genes, 10.0% | 52 out of 533 genes, 9.8% | 0.5989435 |
| regulation of biosynthetic process | 4 out of 20 genes, 20.0% | 108 out of 533 genes, 20.3% | 0.6034466 |
| negative regulation of metabolic process | 2 out of 20 genes, 10.0% | 53 out of 533 genes, 9.9% | 0.6099128 |
| reproduction | 2 out of 20 genes, 10.0% | 55 out of 533 genes, 10.3% | 0.6312257 |
| nucleobase-containing compound biosynthetic process | 2 out of 20 genes, 10.0% | 55 out of 533 genes, 10.3% | 0.6312257 |
| protein localization | 3 out of 20 genes, 15.0% | 84 out of 533 genes, 15.8% | 0.6354324 |
| organic substance transport | 3 out of 20 genes, 15.0% | 84 out of 533 genes, 15.8% | 0.6354324 |
| cell surface receptor signaling pathway | 2 out of 20 genes, 10.0% | 56 out of 533 genes, 10.5% | 0.6415684 |
| cellular biosynthetic process | 4 out of 20 genes, 20.0% | 114 out of 533 genes, 21.4% | 0.6510175 |
| catabolic process | 4 out of 20 genes, 20.0% | 115 out of 533 genes, 21.6% | 0.6586264 |
| aromatic compound biosynthetic process | 2 out of 20 genes, 10.0% | 58 out of 533 genes, 10.9% | 0.661626 |
| heterocycle biosynthetic process | 2 out of 20 genes, 10.0% | 59 out of 533 genes, 11.1% | 0.6713417 |
| cellular nitrogen compound biosynthetic process | 2 out of 20 genes, 10.0% | 59 out of 533 genes, 11.1% | 0.6713417 |
| cellular protein localization | 2 out of 20 genes, 10.0% | 60 out of 533 genes, 11.3% | 0.6808496 |
| cellular macromolecule localization | 2 out of 20 genes, 10.0% | 60 out of 533 genes, 11.3% | 0.6808496 |
| organic substance biosynthetic process | 4 out of 20 genes, 20.0% | 118 out of 533 genes, 22.1% | 0.6808768 |
| cellular localization | 3 out of 20 genes, 15.0% | 91 out of 533 genes, 17.1% | 0.6933702 |
| biosynthetic process | 4 out of 20 genes, 20.0% | 120 out of 533 genes, 22.5% | 0.6952192 |
| organic cyclic compound biosynthetic process | 2 out of 20 genes, 10.0% | 62 out of 533 genes, 11.6% | 0.6992462 |
| macromolecule catabolic process | 2 out of 20 genes, 10.0% | 63 out of 533 genes, 11.8% | 0.7081375 |
| macromolecule localization | 3 out of 20 genes, 15.0% | 94 out of 533 genes, 17.6% | 0.7162217 |
| nucleobase-containing compound catabolic process | 2 out of 20 genes, 10.0% | 66 out of 533 genes, 12.4% | 0.7336029 |
| aromatic compound catabolic process | 2 out of 20 genes, 10.0% | 67 out of 533 genes, 12.6% | 0.741695 |
| positive regulation of cellular metabolic process | 2 out of 20 genes, 10.0% | 69 out of 533 genes, 12.9% | 0.7572972 |
| positive regulation of macromolecule metabolic process | 2 out of 20 genes, 10.0% | 70 out of 533 genes, 13.1% | 0.7648122 |
| cellular nitrogen compound catabolic process | 2 out of 20 genes, 10.0% | 70 out of 533 genes, 13.1% | 0.7648122 |
| heterocycle catabolic process | 2 out of 20 genes, 10.0% | 70 out of 533 genes, 13.1% | 0.7648122 |
| organic cyclic compound catabolic process | 2 out of 20 genes, 10.0% | 70 out of 533 genes, 13.1% | 0.7648122 |
| regulation of macromolecule biosynthetic process | 3 out of 20 genes, 15.0% | 103 out of 533 genes, 19.3% | 0.7776033 |
| regulation of cellular biosynthetic process | 3 out of 20 genes, 15.0% | 105 out of 533 genes, 19.7% | 0.7898056 |
| intracellular transport | 2 out of 20 genes, 10.0% | 78 out of 533 genes, 14.6% | 0.8184092 |
| organic substance catabolic process | 3 out of 20 genes, 15.0% | 111 out of 533 genes, 20.8% | 0.8233957 |
| macromolecule biosynthetic process | 2 out of 20 genes, 10.0% | 79 out of 533 genes, 14.8% | 0.8243357 |
| cellular macromolecule biosynthetic process | 2 out of 20 genes, 10.0% | 79 out of 533 genes, 14.8% | 0.8243357 |
| cellular process | 16 out of 20 genes, 80.0% | 453 out of 533 genes, 85.0% | 0.8333297 |
| single-organism metabolic process | 3 out of 20 genes, 15.0% | 113 out of 533 genes, 21.2% | 0.8336189 |
| nucleic acid metabolic process | 3 out of 20 genes, 15.0% | 114 out of 533 genes, 21.4% | 0.8385541 |
| establishment of localization in cell | 2 out of 20 genes, 10.0% | 82 out of 533 genes, 15.4% | 0.8411554 |
| regulation of macromolecule metabolic process | 4 out of 20 genes, 20.0% | 146 out of 533 genes, 27.4% | 0.8444625 |
| regulation of gene expression | 3 out of 20 genes, 15.0% | 116 out of 533 genes, 21.8% | 0.8480789 |
| small molecule metabolic process | 2 out of 20 genes, 10.0% | 95 out of 533 genes, 17.8% | 0.8991885 |
| nucleobase-containing compound metabolic process | 4 out of 20 genes, 20.0% | 165 out of 533 genes, 31.0% | 0.912732 |
| regulation of cellular macromolecule biosynthetic process | 2 out of 20 genes, 10.0% | 99 out of 533 genes, 18.6% | 0.9128629 |
| cellular aromatic compound metabolic process | 4 out of 20 genes, 20.0% | 169 out of 533 genes, 31.7% | 0.9234389 |
| heterocycle metabolic process | 4 out of 20 genes, 20.0% | 170 out of 533 genes, 31.9% | 0.9259411 |
| cellular nitrogen compound metabolic process | 4 out of 20 genes, 20.0% | 174 out of 533 genes, 32.6% | 0.935289 |
| organic cyclic compound metabolic process | 4 out of 20 genes, 20.0% | 176 out of 533 genes, 33.0% | 0.9395841 |
| regulation of nucleobase-containing compound metabolic process | 2 out of 20 genes, 10.0% | 111 out of 533 genes, 20.8% | 0.9446246 |
| nitrogen compound metabolic process | 4 out of 20 genes, 20.0% | 181 out of 533 genes, 34.0% | 0.9492966 |
| cellular metabolic process | 8 out of 20 genes, 40.0% | 297 out of 533 genes, 55.7% | 0.9524533 |
| regulation of nitrogen compound metabolic process | 2 out of 20 genes, 10.0% | 115 out of 533 genes, 21.6% | 0.9526414 |
| cellular macromolecule metabolic process | 5 out of 20 genes, 25.0% | 216 out of 533 genes, 40.5% | 0.9567507 |
| protein metabolic process | 3 out of 20 genes, 15.0% | 158 out of 533 genes, 29.6% | 0.9644699 |
| macromolecule metabolic process | 5 out of 20 genes, 25.0% | 229 out of 533 genes, 43.0% | 0.9734377 |
| metabolic process | 8 out of 20 genes, 40.0% | 321 out of 533 genes, 60.2% | 0.9818872 |
| cellular protein metabolic process | 2 out of 20 genes, 10.0% | 143 out of 533 genes, 26.8% | 0.9852683 |
| primary metabolic process | 7 out of 20 genes, 35.0% | 304 out of 533 genes, 57.0% | 0.9879046 |
| organic substance metabolic process | 7 out of 20 genes, 35.0% | 311 out of 533 genes, 58.3% | 0.9912877 |
| Gene Ontology term | Genes annotated to the term |
|---|
| muscle organ development | ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| regulation of biological quality | ENSAPLP00000001720, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000002381 |
| regulation of cytokine production | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000004050 |
| muscle structure development | ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| positive regulation of leukocyte activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| striated muscle tissue development | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| positive regulation of cell activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| muscle cell development | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| striated muscle cell development | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle tissue development | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| regulation of anatomical structure size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000002381 |
| regulation of multicellular organismal process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000013090 |
| response to osmotic stress | ENSAPLP00000003050, ENSAPLP00000005411 |
| regulation of blood pressure | ENSAPLP00000003219, ENSAPLP00000002381 |
| ruffle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| striated muscle cell differentiation | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cellular component morphogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| cell projection organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000008118, ENSAPLP00000013090 |
| regulation of response to stress | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of leukocyte activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| regulation of cell activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| locomotion | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| chemotaxis | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| tissue development | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| taxis | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| cell development | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| regulation of actin filament polymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| muscle cell differentiation | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle organ morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue development | ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle fiber development | ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle fiber development | ENSAPLP00000008118, ENSAPLP00000002381 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| organ development | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament length | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein polymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of immune system process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament-based process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of multicellular organismal process | ENSAPLP00000004358, ENSAPLP00000003219, ENSAPLP00000004050 |
| cellular component movement | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000004050, ENSAPLP00000002381 |
| cellular component organization | ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000006049, ENSAPLP00000002381 |
| regulation of response to biotic stimulus | ENSAPLP00000004358, ENSAPLP00000003050 |
| heart morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system process | ENSAPLP00000003219, ENSAPLP00000002381 |
| heart process | ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle tissue development | ENSAPLP00000008118, ENSAPLP00000002381 |
| blood circulation | ENSAPLP00000003219, ENSAPLP00000002381 |
| myofibril assembly | ENSAPLP00000003219, ENSAPLP00000002381 |
| actomyosin structure organization | ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-myosin filament sliding | ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular response to oxidative stress | ENSAPLP00000003219, ENSAPLP00000006873 |
| cellular response to reactive oxygen species | ENSAPLP00000003219, ENSAPLP00000006873 |
| innate immune response | ENSAPLP00000005038, ENSAPLP00000006873 |
| positive regulation of lymphocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| heart contraction | ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle organ development | ENSAPLP00000008118, ENSAPLP00000002381 |
| actin-mediated cell contraction | ENSAPLP00000003219, ENSAPLP00000002381 |
| system development | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| regulation of cellular component size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| single-organism process | ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000011711, ENSAPLP00000001729, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000002381 |
| regulation of localization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of developmental process | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090 |
| response to external stimulus | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| organ morphogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of response to stimulus | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000004050 |
| anatomical structure morphogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| response to chemical stimulus | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| positive regulation of cytokine production | ENSAPLP00000004358, ENSAPLP00000004050 |
| muscle system process | ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle contraction | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of muscle contraction | ENSAPLP00000003219, ENSAPLP00000013090 |
| positive regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| axon guidance | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cardiovascular system development | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| circulatory system development | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| regulation of immune system process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| cellular component organization or biogenesis | ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000006049, ENSAPLP00000002381 |
| response to stress | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050 |
| regulation of cell migration | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of locomotion | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of protein complex assembly | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of cell motility | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005411 |
| response to reactive oxygen species | ENSAPLP00000003219, ENSAPLP00000006873 |
| actin filament-based movement | ENSAPLP00000003219, ENSAPLP00000002381 |
| negative regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| actin filament capping | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of muscle system process | ENSAPLP00000003219, ENSAPLP00000013090 |
| defense response | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873 |
| axonogenesis | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| neuron projection development | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell morphogenesis involved in neuron differentiation | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| neuron projection morphogenesis | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell motility | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000004050 |
| regulation of cellular component movement | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| localization of cell | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000004050 |
| negative regulation of cellular process | ENSAPLP00000004358, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000011840, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004050 |
| negative regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of cellular component biogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of immune effector process | ENSAPLP00000004358, ENSAPLP00000003050 |
| inflammatory response | ENSAPLP00000003050, ENSAPLP00000005038 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of lipid metabolic process | ENSAPLP00000003050, ENSAPLP00000011529 |
| regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| epithelial cell differentiation | ENSAPLP00000003050, ENSAPLP00000008118 |
| negative regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of lymphocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| negative regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| single-organism developmental process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| cell morphogenesis involved in differentiation | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| negative regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000005038, ENSAPLP00000004050 |
| negative regulation of cell death | ENSAPLP00000004358, ENSAPLP00000005038, ENSAPLP00000004050 |
| cellular response to chemical stimulus | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000008118, ENSAPLP00000004050 |
| regulation of cellular process | ENSAPLP00000011840, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049 |
| neuron development | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cellular response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000008118 |
| negative regulation of biological process | ENSAPLP00000004358, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000011840, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004050 |
| biological regulation | ENSAPLP00000011840, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000002381 |
| response to stimulus | ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000002381 |
| blood vessel development | ENSAPLP00000008118, ENSAPLP00000002381 |
| vasculature development | ENSAPLP00000008118, ENSAPLP00000002381 |
| response to oxidative stress | ENSAPLP00000003219, ENSAPLP00000006873 |
| negative regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| cell part morphogenesis | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cell projection morphogenesis | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cellular response to stimulus | ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000006873 |
| multicellular organismal development | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| regulation of transport | ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| response to abiotic stimulus | ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000004050 |
| nucleosome assembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| endocytosis | ENSAPLP00000003050, ENSAPLP00000015337 |
| heart development | ENSAPLP00000003219, ENSAPLP00000002381 |
| negative regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| cell projection assembly | ENSAPLP00000003050, ENSAPLP00000005411 |
| chromatin assembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| positive regulation of response to stimulus | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000005038 |
| cell morphogenesis | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| neuron differentiation | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| anatomical structure development | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| immune system process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873 |
| single-organism cellular process | ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000002381 |
| cell differentiation | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| response to wounding | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005038 |
| DNA packaging | ENSAPLP00000001720, ENSAPLP00000001729 |
| chromatin assembly or disassembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| immune response | ENSAPLP00000005038, ENSAPLP00000006873 |
| positive regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| nucleosome organization | ENSAPLP00000001720, ENSAPLP00000001729 |
| protein-DNA complex assembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| regulation of signal transduction | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000004050 |
| regulation of biological process | ENSAPLP00000011840, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049 |
| cell activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| cell proliferation | ENSAPLP00000004358, ENSAPLP00000006873 |
| extracellular matrix organization | ENSAPLP00000006049, ENSAPLP00000008118 |
| extracellular structure organization | ENSAPLP00000006049, ENSAPLP00000008118 |
| epithelium development | ENSAPLP00000003050, ENSAPLP00000008118 |
| DNA conformation change | ENSAPLP00000001720, ENSAPLP00000001729 |
| protein-DNA complex subunit organization | ENSAPLP00000001720, ENSAPLP00000001729 |
| cellular developmental process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| regulation of defense response | ENSAPLP00000004358, ENSAPLP00000003050 |
| neurogenesis | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| generation of neurons | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000008118 |
| positive regulation of cellular process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of I-kappaB kinase/NF-kappaB cascade | ENSAPLP00000006873, ENSAPLP00000004050 |
| regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000013090 |
| regulation of cell communication | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000004050 |
| regulation of signaling | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000004050 |
| cellular lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038 |
| positive regulation of transport | ENSAPLP00000005411, ENSAPLP00000005038 |
| negative regulation of developmental process | ENSAPLP00000001720, ENSAPLP00000005038 |
| regulation of protein transport | ENSAPLP00000005038, ENSAPLP00000006873 |
| single-multicellular organism process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| homeostatic process | ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000006873 |
| cell migration | ENSAPLP00000003050, ENSAPLP00000004050 |
| actin cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000002381 |
| wound healing | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of system process | ENSAPLP00000003219, ENSAPLP00000013090 |
| positive regulation of hydrolase activity | ENSAPLP00000004358, ENSAPLP00000003219 |
| regulation of establishment of protein localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of cellular response to stress | ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of intracellular protein kinase cascade | ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050 |
| multicellular organismal process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| embryo development | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of anatomical structure morphogenesis | ENSAPLP00000003050, ENSAPLP00000013090 |
| response to growth factor stimulus | ENSAPLP00000003050, ENSAPLP00000004050 |
| cellular response to growth factor stimulus | ENSAPLP00000003050, ENSAPLP00000004050 |
| positive regulation of biological process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050 |
| developmental process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| single-organism transport | ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000011711, ENSAPLP00000013090 |
| response to organic substance | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050 |
| positive regulation of catalytic activity | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219 |
| apoptotic process | ENSAPLP00000004358, ENSAPLP00000002381 |
| programmed cell death | ENSAPLP00000004358, ENSAPLP00000002381 |
| cellular component assembly | ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000001729 |
| regulation of cell death | ENSAPLP00000004358, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000005038, ENSAPLP00000004050 |
| cell death | ENSAPLP00000004358, ENSAPLP00000002381 |
| death | ENSAPLP00000004358, ENSAPLP00000002381 |
| positive regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| nervous system development | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| actin filament-based process | ENSAPLP00000003219, ENSAPLP00000002381 |
| localization | ENSAPLP00000015337, ENSAPLP00000011711, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300 |
| system process | ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular membrane organization | ENSAPLP00000003050, ENSAPLP00000013090 |
| regulation of protein localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| membrane organization | ENSAPLP00000003050, ENSAPLP00000013090 |
| cellular response to organic substance | ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050 |
| macromolecular complex subunit organization | ENSAPLP00000007620, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000002381 |
| cellular response to stress | ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000006873 |
| lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038 |
| chromatin organization | ENSAPLP00000001720, ENSAPLP00000001729 |
| regulation of MAPK cascade | ENSAPLP00000005038, ENSAPLP00000006873 |
| transport | ENSAPLP00000003050, ENSAPLP00000015337, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000011711, ENSAPLP00000013090 |
| regulation of phosphate metabolic process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005038 |
| regulation of phosphorus metabolic process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005038 |
| establishment of localization | ENSAPLP00000003050, ENSAPLP00000015337, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000011711, ENSAPLP00000013090 |
| regulation of cellular localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of multicellular organismal development | ENSAPLP00000003050, ENSAPLP00000001720 |
| positive regulation of molecular function | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of cell differentiation | ENSAPLP00000011529, ENSAPLP00000001720 |
| cellular component biogenesis | ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000001729 |
| protein targeting to membrane | ENSAPLP00000007620, ENSAPLP00000013090 |
| regulation of hydrolase activity | ENSAPLP00000004358, ENSAPLP00000003219 |
| regulation of metabolic process | ENSAPLP00000004358, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000004050 |
| chromosome organization | ENSAPLP00000001720, ENSAPLP00000001729 |
| cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of phosphorylation | ENSAPLP00000003050, ENSAPLP00000005038 |
| macromolecular complex assembly | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729 |
| regulation of catalytic activity | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219 |
| cell adhesion | ENSAPLP00000003050, ENSAPLP00000006049 |
| biological adhesion | ENSAPLP00000003050, ENSAPLP00000006049 |
| cellular macromolecular complex assembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| regulation of primary metabolic process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000004050 |
| multi-organism process | ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000002381 |
| positive regulation of signal transduction | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of cell communication | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of signaling | ENSAPLP00000003050, ENSAPLP00000005038 |
| organelle organization | ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000002381 |
| negative regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000005038 |
| DNA metabolic process | ENSAPLP00000001720, ENSAPLP00000001729 |
| vesicle-mediated transport | ENSAPLP00000003050, ENSAPLP00000015337 |
| positive regulation of protein metabolic process | ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of protein metabolic process | ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000004050 |
| protein complex subunit organization | ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000002381 |
| protein targeting | ENSAPLP00000007620, ENSAPLP00000013090 |
| regulation of cell proliferation | ENSAPLP00000011840, ENSAPLP00000005038 |
| regulation of molecular function | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219 |
| viral reproduction | ENSAPLP00000003050, ENSAPLP00000007620 |
| multi-organism cellular process | ENSAPLP00000003050, ENSAPLP00000007620 |
| regulation of cellular metabolic process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000004050 |
| protein transport | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000013090 |
| signal transduction | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| establishment of protein localization | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000013090 |
| positive regulation of metabolic process | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000004050 |
| signaling | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| single organism signaling | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| cellular catabolic process | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000006873 |
| reproductive process | ENSAPLP00000007620, ENSAPLP00000011529 |
| intracellular protein transport | ENSAPLP00000007620, ENSAPLP00000013090 |
| regulation of cellular protein metabolic process | ENSAPLP00000007620, ENSAPLP00000005038 |
| cell communication | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| negative regulation of macromolecule metabolic process | ENSAPLP00000002553, ENSAPLP00000005038 |
| regulation of biosynthetic process | ENSAPLP00000002553, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000004050 |
| negative regulation of metabolic process | ENSAPLP00000002553, ENSAPLP00000005038 |
| reproduction | ENSAPLP00000007620, ENSAPLP00000011529 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| protein localization | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000013090 |
| organic substance transport | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000013090 |
| cell surface receptor signaling pathway | ENSAPLP00000003050, ENSAPLP00000005038 |
| cellular biosynthetic process | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000005038 |
| catabolic process | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000006873 |
| aromatic compound biosynthetic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| heterocycle biosynthetic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| cellular protein localization | ENSAPLP00000007620, ENSAPLP00000013090 |
| cellular macromolecule localization | ENSAPLP00000007620, ENSAPLP00000013090 |
| organic substance biosynthetic process | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000005038 |
| cellular localization | ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000013090 |
| biosynthetic process | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000005038 |
| organic cyclic compound biosynthetic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| macromolecule catabolic process | ENSAPLP00000007620, ENSAPLP00000011529 |
| macromolecule localization | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000013090 |
| nucleobase-containing compound catabolic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| aromatic compound catabolic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| positive regulation of cellular metabolic process | ENSAPLP00000005038, ENSAPLP00000004050 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000005038, ENSAPLP00000004050 |
| cellular nitrogen compound catabolic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| heterocycle catabolic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| organic cyclic compound catabolic process | ENSAPLP00000007620, ENSAPLP00000009300 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000007620, ENSAPLP00000004050 |
| regulation of cellular biosynthetic process | ENSAPLP00000002553, ENSAPLP00000007620, ENSAPLP00000004050 |
| intracellular transport | ENSAPLP00000007620, ENSAPLP00000013090 |
| organic substance catabolic process | ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300 |
| macromolecule biosynthetic process | ENSAPLP00000007620, ENSAPLP00000011529 |
| cellular macromolecule biosynthetic process | ENSAPLP00000007620, ENSAPLP00000011529 |
| cellular process | ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000002381 |
| single-organism metabolic process | ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000005038 |
| nucleic acid metabolic process | ENSAPLP00000007620, ENSAPLP00000001720, ENSAPLP00000001729 |
| establishment of localization in cell | ENSAPLP00000007620, ENSAPLP00000013090 |
| regulation of macromolecule metabolic process | ENSAPLP00000002553, ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000007620, ENSAPLP00000005038 |
| small molecule metabolic process | ENSAPLP00000009300, ENSAPLP00000005038 |
| nucleobase-containing compound metabolic process | ENSAPLP00000007620, ENSAPLP00000001720, ENSAPLP00000009300, ENSAPLP00000001729 |
| regulation of cellular macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000007620 |
| cellular aromatic compound metabolic process | ENSAPLP00000007620, ENSAPLP00000001720, ENSAPLP00000009300, ENSAPLP00000001729 |
| heterocycle metabolic process | ENSAPLP00000007620, ENSAPLP00000001720, ENSAPLP00000009300, ENSAPLP00000001729 |
| cellular nitrogen compound metabolic process | ENSAPLP00000007620, ENSAPLP00000001720, ENSAPLP00000009300, ENSAPLP00000001729 |
| organic cyclic compound metabolic process | ENSAPLP00000007620, ENSAPLP00000001720, ENSAPLP00000009300, ENSAPLP00000001729 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000002553, ENSAPLP00000003219 |
| nitrogen compound metabolic process | ENSAPLP00000007620, ENSAPLP00000001720, ENSAPLP00000009300, ENSAPLP00000001729 |
| cellular metabolic process | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000004358, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000009300 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000002553, ENSAPLP00000003219 |
| cellular macromolecule metabolic process | ENSAPLP00000004358, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000001729 |
| protein metabolic process | ENSAPLP00000004358, ENSAPLP00000007620, ENSAPLP00000011529 |
| macromolecule metabolic process | ENSAPLP00000004358, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000001729 |
| metabolic process | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000004358, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000009300 |
| cellular protein metabolic process | ENSAPLP00000004358, ENSAPLP00000007620 |
| primary metabolic process | ENSAPLP00000004358, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000009300, ENSAPLP00000005038, ENSAPLP00000001729 |
| organic substance metabolic process | ENSAPLP00000004358, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000009300, ENSAPLP00000005038, ENSAPLP00000001729 |
|